Dipeptidyl-peptidase 4 inhibition: linking metabolic control to cardiovascular protection - Test2 - elhamkhani - TriplyDB

Dipeptidyl-peptidase 4 inhibition: linking metabolic control to cardiovascular protection

Dipeptidyl-peptidase 4 inhibition: linking metabolic control to cardiovascular protection

http://www.wikidata.org/entity/Q27011819

about

Anti-atherogenic and anti-inflammatory properties of glucagon-like peptide-1, glucose-dependent insulinotropic polypepide, and dipeptidyl peptidase-4 inhibitors in experimental animals Adipocyte Accumulation in the Bone Marrow during Obesity and Aging Impairs Stem Cell-Based Hematopoietic and Bone Regeneration Impact of glycemic control with sitagliptin on the 2-year progression of arterial stiffness: a sub-analysis of the PROLOGUE study.DPP-4 inhibitors and heart failure: a potential role for pharmacogenomics.Sitagliptin Attenuates Endothelial Dysfunction of Zucker Diabetic Fatty Rats: Implication of the Antiperoxynitrite and Autophagy.

P2860

Q26749176-AB9019EB-EFD1-489C-9322-5AE8347E9CBF Q33765723-0CAAA72F-3C88-42A5-A6BC-A29E1D761C2A Q37390839-59A08156-EE16-40B8-A9C4-9C084254F868 Q48229830-16B3D79B-9E1F-4167-B211-D206E41E217F Q48270894-58DA33FC-B7DE-448E-80EA-56F099B473C1

P2860

Dipeptidyl-peptidase 4 inhibition: linking metabolic control to cardiovascular protection

http://www.wikidata.org/entity/Q27011819

description

2014 nî lūn-bûn

@nan

2014 թուականին հրատարակուած գիտական յօդուած

@hyw

2014 թվականին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Dipeptidyl-peptidase 4 inhibition: linking metabolic control to cardiovascular protection

@ast

Dipeptidyl-peptidase 4 inhibition: linking metabolic control to cardiovascular protection

@en

Dipeptidyl-peptidase 4 inhibition: linking metabolic control to cardiovascular protection

@nl

type

label

Dipeptidyl-peptidase 4 inhibition: linking metabolic control to cardiovascular protection

@ast

Dipeptidyl-peptidase 4 inhibition: linking metabolic control to cardiovascular protection

@en

Dipeptidyl-peptidase 4 inhibition: linking metabolic control to cardiovascular protection

@nl

prefLabel

Dipeptidyl-peptidase 4 inhibition: linking metabolic control to cardiovascular protection

@ast

Dipeptidyl-peptidase 4 inhibition: linking metabolic control to cardiovascular protection

@en

Dipeptidyl-peptidase 4 inhibition: linking metabolic control to cardiovascular protection

@nl

P1433

Q27011819-22D3AAB0-1486-4301-A1A5-0C659489959D

P1476

Q27011819-E0AD3C26-F597-47CA-8CDE-49AA3FFFB970

P2093

Q27011819-215642E6-8BA2-419F-A0FD-61E14F7FA34F

Q27011819-77574441-3453-49C7-B25C-BFCDF240DCD1

Q27011819-DF666616-7837-450A-B855-3A4159F8C644

P275

Q27011819-5E24BE17-EFAC-4ED0-8F65-B415FC72A30D

P2860

Q27011819-06E68A89-5C20-4C95-A848-BE9C2797F302

Q27011819-0989CCF3-E7A7-4617-8DD7-CC823D65A264

Q27011819-0AAEA29C-D7A9-4D31-A193-3CB1F7096B2A

Q27011819-0F07A55D-2A09-4077-AB43-42F98061C170

Q27011819-0F99976D-322A-4E21-9B48-B1C2189B86D2

Q27011819-139C3A17-1E25-4E01-9329-9250F50BC02E

Q27011819-13BB3D4A-CA27-4F27-B88A-0CBB70079433

Q27011819-1767D12D-F2EB-4D1E-9F8D-AFAAC0603BA7

Q27011819-216C57BD-D7B9-40CA-AFE0-F5F104F28BED

Q27011819-2A40FB7B-3676-4A08-A78F-592DCD2C46B6

P304

Q27011819-41A3EBA7-0405-48BC-9968-F3A2C24E5BA6

P31

Q27011819-82C92B8A-F344-478A-94AE-9DAB45B290C8

Q27011819-B2797A19-6415-468D-A517-4BDCA745D22D

P3181

Q27011819-6E3039FC-5D2E-46E8-B676-19F23BD0F876

P356

Q27011819-B822A1DC-FE2C-4077-A191-F43FE549ECFB

P407

Q27011819-781C661C-4310-42D4-8D12-2433F2E6683C

P433

Q27011819-F5AA2607-5759-4711-A447-5F1AB4908094

P478

Q27011819-4EE992A8-2864-4EFC-BA37-24F060CAAB62

P5008

Q27011819-B7D6310F-8274-4576-B695-72513E68022B

P577

Q27011819-4AECE0C5-680C-43E5-8565-1445E32174CA

P5875

Q27011819-624D252B-B89D-4345-8E3D-4A0B7586CCC9

P698

Q27011819-64BFF631-1011-4F3E-9006-A566DD8578CE

P921

Q27011819-9C04E77A-0F97-4796-8022-B2A22006EDEC

Q27011819-AA7C5600-317D-42C8-83DE-D74C5F775D3F

Q27011819-E8C94612-A2E8-4D5B-88E6-D32DF6F09691

Q27011819-FCB8C1CD-85C5-48B4-ADC1-B8BA7E58B126

P932

Q27011819-26A08C6C-075E-4251-B836-60F26EA6EE89

P3181

P356

13816128113199990474

P1433

Current Pharmaceutical Design

P1476

Dipeptidyl-peptidase 4 inhibition: linking metabolic control to cardiovascular protection

@en

P2093

Avogaro A

http://www.w3.org/2001/XMLSchema#string

Fadini G

http://www.w3.org/2001/XMLSchema#string

de Kreutzenberg S

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 3.0 Unported

P2860

Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders

Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial

Isolation of putative progenitor endothelial cells for angiogenesis

Effect of exogenous or endogenous gastric inhibitory polypeptide (GIP) on plasma triglyceride responses in rats

Linagliptin improves insulin sensitivity and hepatic steatosis in diet-induced obesity

Adipokines in inflammation and metabolic disease

Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice.

The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature

The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha.

Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat)

P304

2387-94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4955335

http://www.w3.org/2001/XMLSchema#string

P356

10.2174/13816128113199990474

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

248703767

http://www.w3.org/2001/XMLSchema#string

P698

23844811

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

mechanism of action

cardiovascular disease

maturity-onset diabetes of the young

P932

4030590

http://www.w3.org/2001/XMLSchema#string